Q32 Bio, Inc. (QTTB)
7.77
-0.24
(-3.00%)
USD |
NASDAQ |
Oct 15, 16:00
7.80
+0.03
(+0.39%)
After-Hours: 20:00
Q32 Bio Cash from Operations (TTM) : -19.83M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.83M |
| March 31, 2026 | -27.40M |
| December 31, 2025 | -33.54M |
| September 30, 2025 | -38.79M |
| June 30, 2025 | -54.08M |
| March 31, 2025 | -65.65M |
| December 31, 2024 | -67.72M |
| September 30, 2024 | -67.00M |
| June 30, 2024 | -31.58M |
| March 31, 2024 | -20.73M |
| December 31, 2023 | -18.68M |
| September 30, 2023 | -35.16M |
| June 30, 2023 | -75.99M |
| March 31, 2023 | -95.47M |
| December 31, 2022 | -113.66M |
| September 30, 2022 | -116.89M |
| Date | Value |
|---|---|
| June 30, 2022 | -117.35M |
| March 31, 2022 | -110.61M |
| December 31, 2021 | -109.75M |
| September 30, 2021 | -90.93M |
| June 30, 2021 | -94.43M |
| March 31, 2021 | -98.31M |
| December 31, 2020 | -94.33M |
| September 30, 2020 | -109.05M |
| June 30, 2020 | -105.65M |
| March 31, 2020 | -99.33M |
| December 31, 2019 | -91.36M |
| September 30, 2019 | -73.10M |
| June 30, 2019 | -61.31M |
| March 31, 2019 | -49.39M |
| December 31, 2018 | -42.56M |
| September 30, 2018 | -12.44M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Intellia Therapeutics, Inc. | -346.64M |
| Beam Therapeutics, Inc. | -359.38M |
| Prime Medicine, Inc. | -156.05M |
| Prelude Therapeutics, Inc. | -33.26M |
| Twist Bioscience Corp. | -53.07M |